Global Peptide Therapeutics Market: Overview
The global market for peptide therapeutics has witnessed development at a significant pace in the past few years, observing a vast rise in the number of peptide drugs being approved and marketed in the global market. The constantly rising number of approvals of peptide-based medicines and the rising array of medical indications finding peptide drugs suitable for effective treatment have cemented the position of peptide therapeutics as one of the most promising fields of the pharmaceutical industry.
Download The Full Brouchre of Report: https://goo.gl/8xFnXL
This report on the global peptide therapeutics market is a detailed analysis of the market, its key segments, and various factors influencing the overall development of the market as observed in the present scenario. As such, the report provides an analytical overview of factors such as growth drivers, challenges, key trends of the present and recent times, regulatory landscape of key regional markets, growth opportunities, and competitive scenario in the global peptide therapeutics market.
Global Peptide Therapeutics Market: Segmentation
The report segments the global peptide therapeutics market on the basis of criteria such as application, marketing status of key peptide drugs in the global market, route of administration, and geography.
On the basis of application, the global peptide therapeutics market has been further segmented into cancer, metabolic disorders, central nervous system disorders, cardiovascular disorders, hematological disorders, infection, acromegaly, respiratory disorders, and gastrointestinal disorders. Of these, cancer is presently the class of disease that rakes in the massive share in the revenue of the global peptide therapeutics market. In the near future, however, the segment of respiratory disorders is expected to emerge as the segment with the most promising growth opportunities.
On the basis of marketing status, the report further segments the market into the key branded peptide drugs approved by major regulatory authorities and available for sale in the global market. This segment includes an analysis of leading peptide-based drugs such as Zoladex, Angiomax, Copaxone, Velcade, Forteo, Victoza, and Sandostatin. These drugs are classified on the basis of their status as branded drugs and generic drugs. This section also presents a thorough analysis of the impact of generic peptide drugs on the overall development of the global peptide therapeutics market in the next few years.
On the basis of route of administration, the report segments the market into parenteral and oral. This segment provides the reader a thorough account of the key trends observed in the market related to course of administration of peptide-based drugs. One of the key trends in this area highlighted in the report includes the rising demand for drugs that are convenient to administer.
Global Peptide Therapeutics Market: Geographical and Competitive Dynamics
The report presents a detailed overview of the peptide therapeutics market across key regional markets including Asia Pacific, North America, Europe, and Middle East and Africa. Share and contribution of these regional markets on the revenue of the global market. Aspects such as the presence of key manufacturers, research bodies, growth opportunities, and regulatory aspects governing the peptide therapeutics market and its development in these regions are also analyzed. With the vast rise in prevalence of a large number of chronic diseases and the large population base, Asia Pacific has been highlighted as one of the most promising regions for the peptide therapeutics market.
The company profile section of the report includes a detailed overview of some of the leading players operating in the global peptide therapeutics market. As such, detailed profiles of companies such as CordenPharma International GmbH, Amgen, Inc., Bachem Holding AG, AstraZeneca plc, PolyPeptide Group, Eli Lilly & Co., Merck & Co., Lonza, Inc., Teva Pharmaceutical Industries Limited, Ipsen S.A., Novo Nordisk A/S, Novartis AG, Takeda Pharmaceutical Company Limited, Sanofi, and Roche Holdings AG are included.
Major regions analyzed under this research report are:
- North America
- Asia Pacific
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453